About Macter International Ltd. 
Macter International Ltd.
Pharmaceuticals & Biotechnology
Macter International Ltd is a Pakistan-based pharmaceutical company. The Company’s primary activity is to manufacture and market pharmaceutical products. It offers a diversified portfolio of pharmaceutical products covering all therapeutic categories including antibiotics, anti-allergy, cardiovascular and Anti-viral infections. Its offered product under various therapeutic categories, includes DX3 Softgel, Macdronic 5mg, Macdronic 4mg , MAclimta , Milast, MACIVY, MACLINZA, Avelia Sachet, SANTE IV, Maclusa, Nurica, Alenor, Atizox, Bismol, Buphain, Cadla, Carac, Carac-H, Co-Amoxi, Dexodine, Demeco, Dicaine, DX3 Softgel, Ecavir, Epilepsin, Epuram, Esante, Glio, Hart, Heberon Alfa R, Inspirol, Itogaurd, Lefanor, Locril, Locril Plus, Mac-Mether, Macprofen, Macdicol, Macticort, Mitaz, Proberry Probiotic Capsule, Sante Plus, Setzine, Sofomac, Tacip, tio-Veez and Zincasa.
Company Coordinates 
Company Details
F-216, S.I.T.E , KARACHI None : 75700
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Amanullah Kassim
Independent Non-Executive Chairman of the Board
Mr. Asif Misbah
Chief Executive, Executive Director
Mr. Swaleh Misbah Khan
Executive Director
Mr. Sheikh Aamir Naveed
Executive Director
Mr. Syed Anis Ahmad Shah
Director
Mr. Muhammad Chawla
Director
Mr. Tariq Wajid
Director
Ms. Masarrat Misbah
Non-Executive Director
Revenue and Profits:
Net Sales:
2,536 Million
(Quarterly Results - Mar 2025)
Net Profit:
91 Million
Pharmaceuticals & Biotechnology
PKR 15,392 Million (Small Cap)
21.00
NA
0.62%
0.14
22.19%
4.11






